Possible association of a reduction in cardiovascular events with blood donation.

D. G. Meyers, D. Strickland, P. A. Maloley, J. K. Seburg, J. E. Wilson, B. F. McManus

Department of Internal Medicine, Kansas University College of Medicine, Kansas City 66160-7378, USA.

Correspondence to:
dmeyers{at}kumc.edu

BACKGROUND: The iron hypothesis suggests that females are protected from atherosclerosis by having lower iron stores than men, thus limiting oxidation of lipids. OBJECTIVE: To test the iron hypothesis by comparing cardiovascular event rates in whole blood donors compared with nondonors. DESIGN: Prospective cohort with telephone survey follow up. SETTING: The State of Nebraska, USA. PARTICIPANTS: A sample was selected from the Nebraska Diet Heart Survey (NDHS) restricting for age > or = 40 years and absence of clinically apparent vascular diseases at time of enrollment in to NDHS (1985-87). MAIN OUTCOME MEASURES: The occurrence of cardiovascular events (myocardial infarction, angina, stroke), procedures (angioplasty, bypass surgery, claudication, endarterectomy), nitroglycerin use, or death (all cause mortality), and level of blood donation. RESULTS: Participants were 655 blood donors and 3200 non-donors who differed in education, physical activity, diabetes, and frequency of antihypertensive treatment; 889 were lost to follow up. Sixty four donors and 567 non-donors reported cardiovascular events (crude odds ratio = 0.50, 95% confidence interval (CI) 0.38-0.66). The benefit of donation was confined to non-smoking males (adjusted odds ratio 0.67, 95% CI 0.45-0.99). Benefit was limited to current donors (the most recent three years). No additional benefit resulted from donating more than once or twice over three years. CONCLUSION: In support of the iron hypothesis, blood donation in non-smoking men in this cohort was associated with reduced risk of cardiovascular events. A randomised clinical trial is warranted to confirm these findings as the observed personal health benefit of donation has public policy ramifications.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Edgren, G., Nyren, O., Melbye, M. (2008). Cancer as a Ferrotoxic Disease: Are We Getting Hard Stainless Evidence?. JNCI J Natl Cancer Inst 100: 976-977 [Full Text]  
• Vari, I. S., Balkau, B., Kettaneh, A., Andre, P., Tichet, J., Fumeron, F., Caces, E., Marre, M., Grandchamp, B., Ducimetiere, P., for the DESIR Study Group, (2007). Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 30: 1795-1801 [Abstract] [Full Text]  
• Sullivan, J. L. (2005). Stored Iron and Vascular Reactivity. Arterioscler. Thromb. Vasc. Bio. 25: 1532-1535 [Full Text]  
• Zheng, H., Cable, R., Spencer, B., Votto, N., Katz, S. D. (2005). Iron Stores and Vascular Function in Voluntary Blood Donors. Arterioscler. Thromb. Vasc. Bio. 25: 1577-1583 [Abstract] [Full Text]  
• Pennings, G (2005). Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients. J. Med. Ethics 31: 69-72 [Abstract] [Full Text]  
• Alpert, P. T. (2004). New and Emerging Theories of Cardiovascular Disease: Infection and Elevated Iron. Biol Res Nurs 6: 3-10 [Abstract]  
• Alpert, P. T. (2004). New and Emerging Theories of Cardiovascular Disease: Response to Commentaries. Biol Res Nurs 6: 21-23  
• Gunn, I R, Maxwell, F K, Gaffney, D, McMahon, A D, Packard, C J (2004). Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy. Heart 90: 304-306 [Abstract] [Full Text]  
• Ramakrishna, G., Rooke, T. W, Cooper, L. T (2003). Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med 8: 203-210 [Abstract]  
• Knuiman, M. W., Divitini, M. L., Olynyk, J. K., Cullen, D. J., Bartholomew, H. C. (2003). Serum Ferritin and Cardiovascular Disease: A 17-Year Follow-up Study in Busselton, Western Australia. Am J Epidemiol 158: 144-149 [Abstract] [Full Text]  
• Sempos, C. T (2002). Do body iron stores increase the risk of developing coronary heart disease?. Am. J. Clin. Nutr. 76: 501-503 [Full Text]  
• Kletzmayr, J., Sunder-Plassmann, G., Horl, W. H. (2002). High dose intravenous iron: a note of caution. Nephrol Dial Transplant 17: 962-965 [Full Text]  
• Ma, J., Stampfer, M. J. (2002). Body Iron Stores and Coronary Heart Disease. Clin. Chem. 48: 601-603 [Full Text]  
• Sullivan, J. L., Ascherio, A., Rimm, E. B., Giovannucci, E., Willett, W. C., Stampfer, M. J. (2001). Blood Donation Without Adequate Iron Depletion: An Invalid Test of the Iron Hypothesis. Circulation 104 : e149-e149 [Full Text]  
• Haidari, M., Javadi, E., Sanati, A., Hajilooi, M., Ghanbili, J. (2001). Association of Increased Ferritin with Premature Coronary Stenosis in Men. Clin. Chem. 47: 1666-1672 [Abstract] [Full Text]  
• Ascherio, A., Rimm, E. B., Giovannucci, E., Willett, W. C., Stampfer, M. J. (2001). Blood Donations and Risk of Coronary Heart Disease in Men. Circulation 103: 52-57 [Abstract] [Full Text]  
• Sullivan, J. L (2000). Correspondence: The iron hypothesis: claim vs. hypothesis. Vasc Med 5: 127-128  
• Sullivan, J. L. (1999). Iron and the Genetics of Cardiovascular Disease. Circulation 100: 1260-1263 [Full Text]  
• de Valk, B., Marx, J. J. M. (1999). Iron, Atherosclerosis, and Ischemic Heart Disease. Arch Intern Med 159: 1542-1548 [Abstract] [Full Text]  
• Klipstein-Grobusch, K., Koster, J. F, Grobbee, D. E, Lindemans, J., Boeing, H., Hofman, A., Witteman, J. C. (1999). Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69: 1231-1236 [Abstract] [Full Text]  
• SLOOP, G. D (1998). Possible association of a reduction in cardiovascular events with blood donation. Heart 79: 422-422 [Full Text]